Sébastien Gagné

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Bernard Côté, Jason D. Burch, Ernest Asante‐Appiah et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 97 citations

Medicine, Antiviral Drug Development, Antiviral Therapy +11

Standardized Procedure for the Simultaneous Determination of the Matrix Effect, Recovery, Process Efficiency, and Internal Standard Association

Jean-François Bienvenu, Gilles Provencher, Patrick Bélanger et al. · Analytical Chemistry · 2017 · 68 citations

Internal Standard Association, Engineering, Measurement +26

Comprehensive Proteomics Approach in Characterizing and Quantifying Allergenic Proteins from Northern Shrimp: Toward Better Occupational Asthma Prevention

Anas M. Abdel Rahman, Sandip D. Kamath, Sébastien Gagné et al. · Journal of Proteome Research · 2012 · 57 citations

The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14

Jacques Yves Gauthier, Michel Belley, Denis Deschênes et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 55 citations · Full text

Pharmaceutical Science, Derivative (Chemistry), Biochemistry +9

Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14

Joël Robichaud, Jean‐François Fournier, Sébastien Gagné et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 50 citations

Pharmacological Study, Biochemistry, Medicine +7